company news

Medline’s Extensive Distribution Network Sparks Expanded Partnership With BioDerm

Dave Dunlap Blogs, Catheter Securement, Company News Leave a comment

Medline’s Extensive Distribution Network Sparks Expanded Partnership With BioDerm

Medical supplier awarded exclusive distribution rights to CathGrip, Freederm and BioPlus+

Northfield, Ill., Aug. 28, 2018 – Medline today announced an expanded distribution partnership with BioDerm®, Inc. that provides the company with exclusive rights to three additional products under BioDerm’s portfolio of urinary management, securement, and skin protection devices. This agreement demonstrates Medline’s dedication to providing clinically proven urological products that help enhance patient outcomes and experiences while driving best practice among clinicians.

Under the terms of the agreement, Medline has exclusive marketing and distribution rights to acute care facilities in the United States and its protectorates for the following products:

CathGrip®: This universal securement device is made from proprietary hydrocolloid that is hypoallergenic and latex free, and the skin-friendly adhesive helps prevent skin tearing and irritation while the patent pending soft straps are designed to reduce pressure injuries.
Freederm™: Formulated to instantly remove hydrocolloid, tapes, and bandages, FreeDerm is BioDerm’s trademark proprietary adhesive remover, and is available in spray or ampoule form.
BioPlus+™: The proprietary skin prep wipes provide a barrier film layer directly on the skin to improve the adhesion of hydrocolloids, appliances, tapes, and bandages.

Under Medline’s partnership with BioDerm that began in January of this year, the company also exclusively markets and distributes the Men’s Liberty Acute™, a male external catheter designed as a means of avoiding Foley catheter and condom catheter use by men within the appropriate patient diagnosis segment.

“We couldn’t be more pleased with Medline and our partnership with the Urology division. What started as a single product arrangement has now expanded quickly to our other securement and skin protection lines due to their superior performance and clinical benefits,” says Gaet Tyranski, president of BioDerm.

For more information on Medline’s comprehensive portfolio of urology products, visit https://www.medline.com/category/Urology/cat330003.

About Medline

Medline is a global manufacturer and distributor serving the healthcare industry with medical supplies and clinical solutions that help customers achieve both clinical and financial success. Headquartered in Northfield, Ill., the company offers 550,000+ medical devices and support services through more than 1,600 direct sales representatives who are dedicated points of contact for customers across the continuum of care. For more information on Medline, go to www.medline.com or http://www.medline.com/social-media to connect with Medline on its social media channels.

About BioDerm

BioDerm, Inc. is one of the nation’s leading manufacturers of proprietary hydrocolloid products for urinary management, securement, infection control and skin protection. Based in Largo, FL, a predominance of Bioderm’s products are manufactured locally. The company challenges accepted inferior standards of care by creating products that reduce infection rates, add comfort and reliability, and improve quality of life. BioDerm’s products are sold in over 20 countries worldwide. For more information on BioDerm’s line of products, visit www.Bioderminc.com or www.MensLiberty.com.


Rachel Scharfman Joins BioDerm, Inc. as V.P. of Sales & Marketing

Matt Geary Blogs, Company News Leave a comment

Rachel Scharfman BioDermExperienced Marketing Executive to Spearhead Major Growth at Largo Manufacturer

Largo, July 5, 2017:  BioDerm, Inc., a local medical device manufacturer, announced the appointment of Rachel Scharfman as V.P of Sales & Marketing.

Scharfman will be responsible for accelerating BioDerm’s aggressive growth plans for 2017 and beyond. She will advance BioDerm’s diversification of products as well as supporting BioDerm’s B2B and B2C marketing and sales efforts.

Mrs. Sharfman is an experienced marketing executive recognized for driving measurable results and global brand awareness. Prior to joining BioDerm in 2017, Mrs. Scharfman lead a team at DenTek Oral Care responsible for global brand management, traditional and digital marketing communication, design and consumer affairs for over 30 countries around the world. She was the acting CMO/VP of Marketing during the private equity sale process, helping achieve 12X EBITDA.

Mrs. Scharfman worked for Almar Sales from 2008 to 2013 as a Brand Marketing Manager, where she had the opportunity to build and market several ecommerce websites for B2B and B2C. She also worked to relaunch and manage the Expressions family of brands, numerous Wonka and Nestle licensed cosmetics, and My Princess Academy. Prior to Almar she worked for Pokemon USA from 2004 to 2008, advancing to an Associate Manager, Marketing & Events at the worldwide headquarters of one of the most popular entertainment properties in the world. Mrs. Scharfman holds a MBA from the University of Florida, BS in Business Management, and a BA in Theater from Florida State University.

About BioDerm, Inc. Headquartered in Largo, FL, BioDerm is one of the nation’s leading manufacturers of hydrocolloid products for urinary management, infection control and skin protection. BioDerm, Inc. is the manufacturer of Men’s Liberty, a male external catheter designed especially for community dwelling men, the ReliaFit™ Male Urinary Device, the next generation external catheter designed for hospital use and CathGrip®, a universal hydrocolloid securement line which can help reduce tube dislodgement and infection. All BioDerm’s products aim to provide a superior patient experience through added comfort and reliability.


Gaet Tyranski Joins BioDerm, Inc. as Company President

Matt Geary Blogs, Company News 1 Comment

Gaet Tyranski BioDermVeteran Healthcare Executive to Spearhead Major Growth at Largo Manufacturer

Largo, January 5, 2016:  Today BioDerm, Inc., a local medical device manufacturer, announced the appointment of Gaet Tyranski as President. Tyranski’s appointment is effective immediately.

Tyranski will be responsible for accelerating BioDerm’s aggressive growth plans for 2016 and beyond. Tyranski will oversee BioDerm’s diverse manufacturing and R&D portfolio as well as supporting BioDerm’s B2B and B2C marketing and sales efforts.

Tyranski is a global P&L Executive with a proven track record of organic and inorganic growth, continuous improvement, customer satisfaction and employee development.  He is a veteran of multiple rapid-growth organizations, including start-ups and multi-million-dollar healthcare manufacturers and service providers.

“Gaet has delivered exceptional results for next generation technologies at Synergy Health and Jabil Circuit,” said Gary Damkoehler, BioDerm’s Chief Executive Officer. “His expertise will help shape the thinking of one of the fastest growth medical device companies as we expand our clients to include new international markets and US health systems to improve the quality of care patients receive.”

“BioDerm, Inc. is one of the most exciting companies I’ve seen in a long time,” said BioDerm’s President, Gaet Tyranski, “Joining the BioDerm family is an exceptional opportunity to expand the sales and product footprint for a truly exciting disposable medical technology that helps improve patients’ quality of life.  BioDerm is poised for rapid growth over the next several years and I am ecstatic about leading the team to achieve superior results for our customers and our shareholders.”

Prior to joining BioDerm, Tyranski was with Jabil Circuit in progressive roles for 14 years, before moving to Synergy Health, a global sterilization services company, in 2014 where he was President, Applied Sterilization Technologies – Americas. Gaet has a BA in economics and political science from Bucknell University and a MBA from the University of Florida. He is also a Board Member of the Florida Medical Manufacturers Consortium (FMMC).

About BioDerm, Inc. Headquartered in Largo, FL, BioDerm is one of the nation’s leading manufacturers of hydrocolloid products for urinary management, infection control and skin protection. BioDerm, Inc. is the manufacturer of Men’s Liberty, a male external catheter designed especially for community dwelling men, the ReliaFit™ Male Urinary Device, the next generation external catheter designed for hospital use and CathGrip®, a universal hydrocolloid securement line which can help reduce tube dislodgement and infection. All BioDerm’s products aim to provide a superior patient experience through added comfort and reliability.


Join Us at Medica 2015 in Dusseldorf!

Matt Geary Blogs, Company News Leave a comment , , , ,

Medica

MedicaKicking off on November 16th – the Medica tradeshow is the world largest event for the medical sector. BioDerm is attending for the second straight year! Featuring over 4800 companies and 130,000 attendees, Medica is a once a year opportunity to promote our products to a growing international audience.

If you or someone you know if going to be in Dusseldorf – please come and visit! We will be located in the Florida Pavilion – Halle 16, Stand D04. We will have both our National Sales Manager, Jim Terpstra, and our Clinical Marketing Specialist, Sarah Woodward in attendance to answer all your questions.

BioDerm is currently seeking new distribution relationships in Europe, Asia and South America. We currently export to Canada, Peru, the Netherlands and the United Kingdom. BioDerm is a manufacturer of hydrocolloid urological and catheter securement products. We provide high quality, innovative product solutions that reduce healthcare costs by preventing avoidable complications in the acute care and consumer marketplace.

For more information on our products please download our Corporate Profile!


Medical Device Related Pressure Ulcers: White Paper Published!

Matt Geary Catheter Securement, Company News Leave a comment , , , , ,

Best Practices to Prevent Medical Device Related Pressure Ulcers!

 

Pressure ulcers cost the US healthcare system more than $11 billion dollars annually. With over 1/3 of those costs associated with medical device usage, clinicians, manufacturers and purchasing have a unique opportunity to implement a coordinated strategy to reduce or eliminate these ulcerations.

Portrait of an African patient lying in his bed with his nurse by his side

Portrait of an African patient lying in his bed with his nurse by his side

Medical device related pressure ulcers (MDR-PU) are unique due to their development away from the traditional bony prominences seen with other pressure ulcers. In addition, they are much more likely to be identified at a later stage of development (74%)2, increasing treatment costs (Avg: $10,700)11 and length of stay (adding 4-10 days excess LOS)5.

In order to assist acute care facilities in reducing the clinical and financial burden of these events, we have identified the key components of a risk mitigation protocol. This includes interventions from clinicians, modifications of purchasing processes and partnerships with medical device manufacturers to build in risk mitigation from the outset. Implementation of these protocols may help reduce the cost and incidence of medical device related ulcers.


Sticky Notes from BioDerm

Matt Geary Company News Leave a comment

Welcome and thank you for visiting! Today everyone here at BioDerm is thrilled to kick off our new blog dedicated to improving healthcare by challenging accepted standards of care and outdated products that are ripe for replacement. We utilize our proprietary hydrocolloid technology to manufacture innovative new devices for catheter securement and urology.

We’ll be posting here over the coming weeks and months to share exciting news, information and product updates with all of you. If you’d like to get the news before anyone else, be sure to subscribe using the box to the right!

Orange Arrow2